Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/124407
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Consensus statement on the use of clozapine during the COVID-19 pandemic |
Author: | SIskind, D. Horner, W. Clark, S.R. Correll, C.U. Hasan, A. Howes, O. Kane, J. Kelly, D.L. Laitman, R. Lee, J. MacCabe, J.H. Myles, N. Nielsen, J. Schulte, P.F. Taylor, D. Verdoux, H. Wheeler, A. Freudenreich, O. |
Citation: | Journal of Psychiatry and Neuroscience, 2020; 45(3):222200061-1-223 |
Publisher: | Canadian Medical Association |
Issue Date: | 2020 |
ISSN: | 1180-4882 1488-2434 |
Statement of Responsibility: | Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich |
Description: | Published online on April 3, 2020. Psychopharmacology for the Clinician. To be published in vol. 45, no. 4? |
Rights: | © 2020 Joule Inc. or its licensors |
DOI: | 10.1503/jpn.200061 |
Published version: | http://jpn.ca/wp-content/uploads/2020/04/45-4-200061.pdf |
Appears in Collections: | Aurora harvest 4 Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.